Liver transplant biopsy study using TruGraf
Part of Immune system & allergy clinical trials.
This study uses a blood test called TruGraf to check for liver transplant problems. It may help diagnose issues without a biopsy.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You received a single-organ liver transplant (only a liver, no other organs).
- You are 18 years or older.
- You are willing and able to give your consent.
- You are scheduled for a liver biopsy or had one within the last 48 hours.
- You have not received treatment for rejection (like IV steroids) before the biopsy.
- The biopsy is not being done to check for cancer.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a special blood test can help monitor your new kidney after transplant. It may help doctors spot problems earlier and improve kidney health.
This study tests whether a small biopsy taken from a donor heart before transplant can predict how well the heart will work after surgery. The goal is to improve transplant success for recipients.
This study looks at whether genetic testing of a tissue sample (biopsy) can help doctors more accurately diagnose rejection after a liver transplant. It is for people who have already been diagnosed with rejection and have a stored tissue sample available.
This study checks whether a special blood test can predict who is at higher risk of graft loss (the transplanted liver not working well) and death after a liver transplant. It may help doctors identify higher-risk patients earlier and tailor follow-up care.
This trial uses DNA testing and gene expression profiling to see if kidney transplant recipients can safely switch to a belatacept-only immunosuppression regimen. The goal is to simplify your anti-rejection drugs while keeping your kidney healthy.
This study tests a blood test called GraftAssure that may help doctors detect if your body is rejecting your new kidney. By monitoring this, the test could help prevent kidney damage and improve transplant outcomes.
Hear when a new Acute Graft Rejection trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.